A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2002
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist
12/11/2002	CN1384816A Polymorphic forms of sertraline hydrochloride
12/11/2002	CN1384748A Mesoprogestins (progesterone receptor modulators) as component of female contraceptives
12/11/2002	CN1384746A 单位剂量形式 Unit dosage forms
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384114A Growth promoting factor and its prepn and use
12/11/2002	CN1384109A Compound with breeding-resisting action and its prepn
12/11/2002	CN1383874A External medicine for treating mastopathy and its prepn
12/11/2002	CN1383872A Kidney-invigorating and Yang-strenghtening wine
12/11/2002	CN1383866A Medicine for treating primary dysmenorrhea and its prepn
12/11/2002	CN1383859A Health tea
12/11/2002	CN1383852A Kidney-strengthening and pregnancy assisting granule
12/11/2002	CN1383820A Composite medicine for treating male's impotence and prospermia and its prepn process
12/11/2002	CN1095841C 化合物 Compound
12/11/2002	CN1095668C Use of combination of progestational agent and nitric oxide synthetase substrate and/or donor in prep. of medicine for treatment of preeclampsia and preterm labor
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492358 For treatment of sexual disorders, male erectile dysfunction
12/10/2002	CA2208792C Substituted indazole derivatives
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097033A2 Antibodies that immunospecifically bind to trail receptors
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002096932A1 Transporters and ion channels
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases
12/05/2002	WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096883A1 Tricyclic compounds useful as angiotensin ii agonists
12/05/2002	WO2002096866A2 Thiolalkyl benzoic acid derivatives
12/05/2002	WO2002096420A2 Method for treating nerve injury caused by surgery
12/05/2002	WO2002096411A1 Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
12/05/2002	WO2002096408A1 Coenzyme q and eicosapentaenoic acid (epa)
12/05/2002	WO2002096363A2 Method for treating fibrotic diseases or other indications
12/05/2002	WO2002096362A2 Method for treating fibrotic diseases or other indications vi
12/05/2002	WO2002096358A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002	WO2002070557A3 Nuclear hormone receptor ligand binding domain
12/05/2002	WO2002062798A3 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
12/05/2002	WO2002038732A3 Human testis specific serine/threonine kinase
12/05/2002	WO2002020766A3 G-csf analog compositions and methods
12/05/2002	WO2002009637A3 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
12/05/2002	WO2001098362A3 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/05/2002	WO2001090142A3 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS
12/05/2002	WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
12/05/2002	US20020183524 Preparations and use of an Ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/05/2002	US20020183507 Novel human GABA receptor proteins and polynucleotides encoding the same
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183375 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
12/05/2002	US20020183367 2,1-Oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
12/05/2002	US20020183365 Therapy or ameliorating an indication of the invention in an animal, including a human, comprising administering heteroaryl compond
12/05/2002	US20020183354 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders
12/05/2002	US20020183353 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
12/05/2002	US20020183352 Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
12/05/2002	US20020183351 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
12/05/2002	US20020183346 Tricyclic androgen receptor modulator compounds and methods
12/05/2002	US20020183329 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
12/05/2002	US20020183319 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
12/05/2002	US20020183318 Novel derivatives of flavones, xanthones and coumarins
12/05/2002	US20020183314 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers
12/05/2002	US20020183311 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
12/05/2002	US20020183281 For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, pain
12/05/2002	US20020183263 Nutritional preparation comprising ribose and medical use thereof
12/05/2002	US20020182269 Cucumis melo extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance
12/05/2002	US20020182265 Lubricious coatings for substrates
12/05/2002	CA2449199A1 Coenzyme q and eicosapentaenoic acid (epa)
12/05/2002	CA2449160A1 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002	CA2449019A1 Method for treating nerve injury caused by surgery
12/05/2002	CA2448320A1 Ribozyme based treatment of female reproductive diseases
12/05/2002	CA2448306A1 Method for treating fibrotic diseases or other indications
12/05/2002	CA2448294A1 Method for treating fibrotic diseases or other indications vi
12/05/2002	CA2448246A1 Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2447662A1 Transporters and ion channels
12/05/2002	CA2446723A1 Antibodies that immunospecifically bind to trail receptors
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/04/2002	EP1262194A1 Remedies and preventives for antiphospholipid antibody syndrome
12/04/2002	EP1262190A1 Rfrp-containing prolactin secretion regulatory agent
12/04/2002	EP1262189A1 Leptin-resistance ameliorating agents
12/04/2002	EP1262182A2 Methods and compositions for treating hypertension, angina and other disorders using optically pure(-) amlodipine
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261706A2 Egg specific surface proteins
12/04/2002	EP1261638A2 Human fgf-23 gene and gene expression products
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261609A1 Triazolotriazinones and the use thereof
12/04/2002	EP1261588A1 New imidazole derivatives
12/04/2002	EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
12/04/2002	EP1261371A1 Membrane estrogen receptor-directed therapy in breast cancer
12/04/2002	EP1261363A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/04/2002	EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261328A1 Il-8 receptor antagonists
12/04/2002	EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002	EP0984980B1 20-aralkyl-5alpha-pregnane derivatives
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/04/2002	CN1383386A Drug delivery device for insertion in vagina, rectum of nasal cavity
12/04/2002	CN1383380A 干细胞增强材料 Stem Cell Reinforcements
12/04/2002	CN1382697A Human testis development specific protein-28 gene coding protein
12/04/2002	CN1382696A Human testis development specific protein-25 gene coding protein
12/04/2002	CN1382695A Human testis development specific protein-22 gene coding protein

1 ... 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 ... 557